Clinical trials

  • Mexiletine hydrochloride for Myotonic dystrophy type 1|Myotonic dystrophy type 2
  • ANTI-T LYMPHOCYTE IMMUNOGLOBULIN FOR HUMAN USE, PIG for Peripheral T-cell lymphoma (PTCL)
  • AZD0901 for Gastric cancer | Gastroesophageal junction adenocarcinoma (Claudin 18.2 positive)
  • MEZIGDOMIDE for Relapsed or refractory multiple myeloma
  • AZD0901 for Gastric cancer | Gastroesophageal junction cancer | Pancreatic ductal adenocarcinoma | Biliary tract cancer
  • ACASUNLIMAB for Endometrial carcinoma | Urothelial carcinoma | Triple-negative breast cancer | Squamous cell carcinoma of the head and neck | Cervical cancer
  • HUMAN CANCELLOUS BONE for Meniscus tear | Meniscus injury
  • FLUASTERONE for Cushing's syndrome
  • ipilimumab for Glioblastoma|Glioblastoma multiforme
  • LANIFIBRANOR for Non-alcoholic steatohepatitis (NASH)
  • ELINZANETANT for Vasomotor symptoms (hot flashes) due to adjuvant endocrine therapy
  • Lebrikizumab for Atopic dermatitis